1 CCORT/CCS 2008 Quality Indicators for Acute Myocardial Infarction (AMI) Care-Indicator Definitions CIHR Team Grant in Cardiovascular Outcomes Research.

Slides:



Advertisements
Similar presentations
© 2010, American Heart Association. All rights reserved. Hospital Performance Recognition with the Get with the Guidelines Program and Mortality for Acute.
Advertisements

1 CCORT/CCS 2008 Quality Indicators for Acute Myocardial Infarction (AMI) Care - Introduction CIHR Team Grant in Cardiovascular Outcomes Research Jack.
Acute Myocardial Infarction (AMI) JCAHO Core Measure Project Loyola University Medical Center Team Members: K. McLean MD, M. Morrow MSN, J. Cochran BSN,
Introduction to Core Measures Lynn Benson Preferred Nurse Staffing.
CMS Core Measures Evidence-Based Performance Measurement.
A few basics of cardiac surgery…. Brett Sheridan, MD Assistant Professor Department of Surgery.
CURRENT STATUS OF STRESS TESTING JOHN HAMATY D.O..
Modalities of Cardiac Stress Test
Improved Care for Acute Myocardial Infarction Linking Referral and Receiving Centres – How can We Communicate Better? Dr. James McMeekin AMI Faculty Cardiologist,
1 Dr. Zahoor Ali Shaikh. 2 CORONARY ARTERY DISEASE (CAD)  CAD is most common form of heart disease and causes premature death.  In UK, 1 in 3 men and.
Cardiac Arrhythmias in Coronary Heart Disease SIGN 94.
1 National trends in rates of death and hospital admissions related to acute myocardial infarction, heart failure and stroke, 1994–2004 CIHR Team Grant.
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 53 Management of ST-Elevation Myocardial Infarction.
National Report Card on Hospital care for heart disease in Indigenous Australia Traven Lea, National Manager, Aboriginal and Torres Strait Islander Program.
1 What is… ? Disparities Among Women in Acute Cardiac Care Frances Canet, MD Cath Conference Thursday, May 26, 2011.
Core Measures Evidence-Based Performance Measurement Lynne Hall, RN, BSN Green Belt Six Sigma Updated: 06/16/2011.
Unstable Angina /Non-ST Elevation Myocardial Infarction Critical Pathway Toolkit Adapted from Dr Chris Cannon STRIVE Scientific Committee – 2008 Based.
EHR for Meaningful Use Clinical Quality Measures Dr. Aneel Advani Associate Director for Informatics IHS Office of Information Technology Indian Health.
Congestive Heart Failure Quality Initiatives. SRHS History of CHF Focus Team early 90’s, developed Care Map, adopted education materials and guidelines.
Health Care Effectiveness Summer Quarterly Meeting July 19, 2011.
Indication and contra-indications for cardiac catheterization
ACUTE CORONARY SYNDROME (ACS). ACS Pathophysiology is that of a ruptured or eroded atheromatous plaque. Pathophysiology is that of a ruptured or eroded.
Around-the-Clock Primary Angioplasty: A Process of Care Analysis Comparing Off-Hours and Normal Hours Treatment of Acute STEMI R Leung, D Lundberg, D Galbraith,
1 DIAGNOSTICS OF Acute Coronary Syndromes At the end of this self study the participant will: Verbalize meanings of specific ECG changes: –ST Elevation.
ACS and Thrombosis in the Emergency Setting
DR. ZAHOOR 1.  A 50 year old man presents to clinic with a complaint of central chest discomfort of 2 weeks’ duration, occurring after walking for more.
ACUTE MYOCARDIAL INFARCTION Team Membership Clinical Departments: Cardiology, Cardiovascular Surgery, Emergency Medical Services Hospital Departments:
1 EFFECT STUDY 2 EFFECT STUDY  Set national cardiac care benchmarks for hospitals to work towards 
Cardio Investigations. Patients presenting with chest pain may be identified as having definite or possible angina from their history alone. Risk Factor.
Introduction to Core Measures
Acute Myocardial Infarction (Heart Attack) Committee Membership: B. Majcher, APRN, C. Mulhall, APRN, K. McLean, MD, M. Jarotkiewicz RRT, MS, Administrative.
Nursing and heart failure
Tarunjit Singh Department of Internal Medicine Westchester Medical Center New York Medical College Valhalla NY.
National AMI Information Call February 5, 2008 Patient Safety Initiative.
Component 2: The Culture of Health Care Unit 7: Quality Measurement, Performance Improvement, and Incentive Payment Schemes Lecture 4 This material was.
Which Early ST-Elevation Myocardial Infarction Therapy (WEST) Trial Paul W. Armstrong, WEST Steering Committee Published in The European Heart Journal.
Quality Measurement and Improvement Component 2 / Unit 7d.
6/04 CRUSADE: A National Quality Improvement Initiative C an R apid Risk Stratification of U nstable Angina Patients S uppress AD verse Outcomes with E.
Acute Heart Failure in Apical Ballooning Syndrome (Takotsubo/Stress Cardiomyopathy) Clinical Correlates and Mayo Clinic Risk Score Malini Madhavan, MBBS;
Core Measures 2014 Revised 11/30/13.
Update of 2013 ACCF/AHA Guidelines for STEMI Junbo Ge MD,FACC,FESC,FSCAI Zhongshan Hospital, Fudan University.
Safer Healthcare Now! Acute Myocardial Infarction Presented by Amanda Thompson, Safer Healthcare Now Facilitator.
Acute Coronary Syndromes. Learning outcomes To understand the clinical spectrum of coronary disease To recognise different presentations of the disease.
Atypical Presentations Patients older than 75: frequently no chest pain ECG in evolution (nonspecific ECG changes) Diabetic patients: commonly no chest.
MYOCARDIAL INFARCTION. CASE 1 Mr. A: 38 years old He smokes 1 pack of cigarettes per day He has no other past medical history 8 hours ago, he gets sharp.
Acute Myocardial Infarction February 8, 2006.
Dr.AZDAKI (cardiologist).   Initial monotherapy is successful in many patients with mild primary hypertension (formerly called "essential" hypertension).
HEART FAILURE Team Membership Clinical Departments: Cardiology, Cardiovascular Surgery, Nursing, QRM, CCE, Medical Records Project Coordinators: Carmen.
Key Indicator Components % ASA within 24 hrs of admission % ASA within 24 hrs of admission Reperfusion time (STEMI) Reperfusion time (STEMI) Door to needle.
Date of download: 5/28/2016 Copyright © The American College of Cardiology. All rights reserved. From: 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for.
Date of download: 6/1/2016 Copyright © The American College of Cardiology. All rights reserved. From: Early and long-term clinical outcomes associated.
Date of download: 6/18/2016 Copyright © The American College of Cardiology. All rights reserved. From: Reduction in Treatment Times Through Formalized.
Ten Year Outcome of Coronary Artery Bypass Graft Surgery Versus Medical Therapy in Patients with Ischemic Cardiomyopathy Results of the Surgical Treatment.
HEART FAILURE TEAM MEMBERSHIP DEPARTMENTS OF CARDIOLOGY, CARDIOVASCULAR SURGERY, MEDICINE, NURSING, QUALITY AND RESOURCE MANAGEMENT, THE CENTER FOR CLINICAL.
Date of download: 7/7/2016 From: Management of Stable Ischemic Heart Disease: Summary of a Clinical Practice Guideline From the American College of Physicians/American.
Ridha Chakeer MD PGY3. Objectives: Approximately 5.2 million Americans are affected  accounts for more than 3 million outpatient visits to primary care.
CORONARY ARTERY DISEASE
for the CCORT/CCS AMI Quality Indicator Panel
Eva Kline-Rogers RN, NP, AACC University of Michigan
R. Jay Widmer, MD, PhD, Peter M. Pollak, MD, Malcolm R
Unstable Angina and Non–ST Elevation Myocardial Infarction
STEMI-INITIAL PRESENTATION TIMING 2013 ACC/AHA GUIDELINES
Step Care Therapy for Hypertension in Diabetic Patients
Sex Differences in Clinical Profiles and Quality of Care Among Patients With ST‐Segment Elevation Myocardial Infarction From 2001 to 2011: Insights From.
Global Registry of Acute Coronary Events: GRACE
Measure-specific reasons for exclusion (2010-Q4–2013-Q3).
China PEACE risk estimation tool for in-hospital death from acute myocardial infarction: an early risk classification tree for decisions about fibrinolytic.
R. Jay Widmer, MD, PhD, Peter M. Pollak, MD, Malcolm R
Cardiovascular Epidemiology and Epidemiological Modelling
Presentation transcript:

1 CCORT/CCS 2008 Quality Indicators for Acute Myocardial Infarction (AMI) Care-Indicator Definitions CIHR Team Grant in Cardiovascular Outcomes Research Jack V. Tu MD PhD FRCPC, Laila Khalid MD, Linda Donovan BScN MBA, Dennis T. Ko MD MSc for the CCORT/CCS AMI Quality Indicator Panel Christopher E. Buller MD, Virginia F. Flintoft BN MSc, Thao Huynh MD MSc, Cynthia A. Jackevicius PharmD MSc, Laurie J. Lambert PhD, Michael P. Love MB ChB MD, Michael J. Schull MD MSc, Heather Sherrard BScN MHA, Edward Y.K. Tsoi MD, Alain Vadeboncoeur MD

2 CCORT/CCS 2008 Quality Indicators for AMI Care Indicator Category # Indicators from chart review 17 IIn-hospital process-of-care indicators - 6 pharmacological & 7 nonpharmacological 13 IIOutcome indicator 1 IIISystem indicators 3 Indicators from administrative data 21 IOut-of-hospital process-of-care indicators - 9 pharmacological & 4 nonpharmacological 13 IIOutcome indicators 8 Total 2008 Indicators 38

3 CCORT/CCS 2008 Quality Indicators for AMI Care 1 In-hospital Process-of-Care Indicator /Chart Abstracted (Pharmacological) 1.1 ASA within 24 hrs before hospital arrival or within 3 hrs after hospital arrival 1.2ASA prescribed at hospital discharge 1.3Beta blocker prescribed at hospital discharge 1.4ACEI or ARB prescribed at hospital discharge 1.5Statin prescribed at hospital discharge 1.6Fibrinolytic therapy within 30 minutes after hospital arrival

4 CCORT/CCS 2008 Quality Indicators for AMI Care 2 In-hospital Process-of-Care Indicators/Chart Abstracted (Nonpharmacological) 2.1 ECG within 10 minutes after hospital arrival 2.2 Primary percutaneous coronary intervention (PCI) within 90 minutes after hospital arrival 2.3 Reperfusion therapy in eligible patients with ST-segment elevation MI 2.4 Risk stratification (i.e. cardiac catheterization, exercise stress test, perfusion imaging, stress echocardiography) 2.5 Assessment of left ventricular function 2.6 Smoking cessation advice, counselling or therapy during hospital stay 2.7 Referral to cardiac rehabilitation

5 CCORT/CCS 2008 Quality Indicators for AMI Care 3In-hospital Outcome Indicator/Chart Abstracted 3.1 In-hospital mortality 4In-hospital System Indicators/Chart Abstracted 4.1Fibrinolytic therapy within 60 minutes after call for emergency medical services 4.2Primary PCI within 120 minutes after call for emergency medical services 4.3Pre-hospital 12-lead ECG

6 CCORT/CCS 2008 Quality Indicators for AMI Care 1Out-of-Hospital Process-of-Care Indicators/Administrative Data (Pharmacological) 1.1 Prescription for Beta Blocker filled within 30 days after discharge 1.2Prescription for Beta Blocker filled within 90 days after discharge 1.3Adherence to Beta Blocker therapy 1 year after discharge 1.4 Prescription for ACEI or ARB filled within 30 days after discharge 1.5Prescription for ACEI or ARB filled within 90 days after discharge 1.6Adherence to ACEI or ARB 1 year after discharge 1.7 Prescription for Statin filled within 30 days after discharge 1.8Prescription for Statin filled within 90 days after discharge 1.9Adherence to Statin therapy 1 year after discharge

7 CCORT/CCS 2008 Quality Indicators for AMI Care 2Out-of-Hospital Process-of-Care Indicators/Administrative Data (Nonpharmacological) 2.1Physician visit within 4 weeks after discharge 2.2Median wait time (in days) for cardiac catheterization after MI 2.3Median wait time (in days) for percutaneous coronary intervention (PCI) after MI 2.4Median wait time (in days) for coronary artery bypass graft (CABG) surgery after MI

8 CCORT/CCS 2008 Quality Indicators for AMI Care 3Out-of-Hospital Outcome Indicators/ Administrative Data day mortality 3.21-year mortality day readmission rate because of AMI 3.41-year readmission rate because of AMI day readmission rate because of congestive heart failure 3.61-year readmission rate because of congestive heart failure day readmission rate because of unstable angina 3.81-year readmission rate because of unstable angina

1.1 ASA within 24 hours before hospital arrival or within 3 hours after hospital arrival NumeratorPatients with AMI who received ASA within 24 hrs before hospital arrival or within 3 hours after hospital arrival DenominatorInclusions: Confirmed AMI Exclusions: 1. Active Bleeding on arrival 2. Allergy to ASA 3. Documented reason for nonuse of ASA (e.g. high risk of bleeding or patient refusal) 1. In-hospital Process-of-Care Indicators — Pharmacological

1.2 ASA prescribed at hospital discharge NumeratorPatients with AMI who are prescribed ASA at hospital discharge DenominatorInclusions: Confirmed AMI and alive at discharge Exclusions: 1. Evidence of i) Active bleeding on arrival or ii) Active bleeding during hospital stay 2. Allergy to ASA 3. Documented reason for nonuse of ASA (e.g. high risk of bleeding or patient refusal) 1. In-hospital Process-of-Care Indicators — Pharmacological

1.3 Beta Blocker prescribed at hospital discharge NumeratorPatients with AMI who are prescribed a Beta Blocker at hospital discharge DenominatorInclusions: Confirmed AMI and alive at discharge Exclusions: 1. Bradycardia (heart rate <60 bpm) on day of discharge or day before discharge while not taking beta blocker 2. Conduction disorder defined as a second- or third-degree heart block on ECG on arrival or during hospital stay while not on a pacemaker 3. Allergy or intolerance to beta blocker 4. Documented reason for nonuse of beta blocker (e.g. symptomatic hypotension, systolic blood pressure < 100 mm Hg, severe chronic obstructive pulmonary disease, asthma or patient refusal) 1. In-hospital Process-of-Care Indicators — Pharmacological

1.4 Angiotensin-converting enzyme (ACE) inhibitor or Angiotensin-receptor blocker prescribed at hospital discharge NumeratorPatients with AMI who are prescribed ACEI or ARB at hospital discharge DenominatorInclusions: 1. Patients with AMI alive at discharge and 2. Left ventricular ejection fraction <40% and 3. Patients with diabetes, hypertension, heart failure or chronic kidney disease Exclusions: 1. Severe aortic stenosis 2. Allergy or intolerance to ACEI or ARB 3. Documented reason for nonuse of ACEI or ARB at discharge (e.g. symptomatic hypotension, severe renal dysfunction, hyperkalemia, bilateral renal artery stenosis or patient refusal) 1. In-hospital Process-of-Care Indicators — Pharmacological

1.5 Statin prescribed at hospital discharge NumeratorPatients with AMI who are prescribed a statin at hospital discharge DenominatorInclusions: Confirmed AMI and alive at discharge Exclusions: Documented reason for nonuse of statins (e.g. statin intolerance, liver disease or patient refusal) 1. In-hospital Process-of-Care Indicators — Pharmacological

1.6 Fibrinolytic therapy within 30 minutes after hospital arrival NumeratorPatients with AMI who received fibrinolytic therapy within 30 minutes after hospital arrival DenominatorInclusions: 1. Confirmed AMI and 2. ST-segment elevation or new LBBB on ECG and 3. Fibrinolytic therapy received within 6 hrs after hospital arrival and 4. Fibrinolytic therapy documented as primary reperfusion therapy Exclusions: 1. Fibrinolytic therapy received in ambulance or in field 2. Documented reason for delay in receiving fibrinolytic therapy (e.g. nondiagnostic ECG or patient refusal) 1. In-hospital Process-of-Care Indicators — Pharmacological

2.1 ECG within 10 minutes after hospital arrival NumeratorPatients with AMI who had an ECG within 10 minutes after hospital arrival (triage time or registration time whichever occurs earlier) DenominatorInclusions: Confirmed AMI Exclusions: Documented reason for delay in ECG (e.g. atypical signs or symptoms, ongoing cardiac arrest or patient refusal) 2. In-hospital Process-of-Care Indicators — Nonpharmacological

2.2 Primary percutaneous coronary intervention (PCI) within 90 minutes after hospital arrival NumeratorPatients with AMI who received primary percutaneous coronary intervention (PCI) within 90 minutes after first hospital arrival DenominatorInclusions: 1. Confirmed AMI and 2. ST-segment elevation or new LBBB on ECG, and 3. Primary percutaneous coronary intervention performed within 24 hours after hospital arrival Exclusions: 1. Patients who received fibrinolytic therapy before PCI 2. Documentation of PCI as non-primary 3. Documented reason for delay in PCI (e.g. patient refusal) 2. In-hospital Process-of-Care Indicators — Nonpharmacological

2.3 Reperfusion therapy in eligible patients with ST-segment elevation MI NumeratorPatients with AMI who received reperfusion therapy (fibrinolytic therapy or primary percutaneous coronary intervention [PCI]) DenominatorInclusions: 1. Patients with ST-segment elevation MI or new LBBB on ECG who are eligible for fibrinolytic therapy or primary PCI and 2. Patients who present within 12 hours after symptom onset Exclusions: Documented reason for not receiving reperfusion therapy (e.g. patient refusal) 2. In-hospital Process-of-Care Indicators — Nonpharmacological

2.4 Risk stratification (i.e. cardiac catheterization, exercise stress testing, perfusion imaging or stress echocardiography) NumeratorPatients with AMI who underwent risk stratification (i.e. cardiac catheterization, exercise stress testing, perfusion imaging or stress echocardiography) during hospital stay or were referred for risk stratification (e.g. outpatient or transfer to another hospital) after discharge DenominatorInclusions: Confirmed AMI Exclusions: 1. Primary or rescue percutaneous coronary intervention (PCI) 2. Documented reason for no cardiac catherterization or noninvasive stress test (e.g. physical limitations, do-not-resuscitate status or patient refusal) 2. In-hospital Process-of-Care Indicators — Nonpharmacological

2.5 Left Ventricular Function Assessment NumeratorPatients with AMI who had assessment of left ventricular function (e.g. via echocardiography, radionuclide angiography or left ventriculography) during their hospital stay or were referred for assessment after hospital discharge DenominatorInclusions: Confirmed AMI Exclusions: 1. Primary or rescue percutaneous coronary intervention (PCI ) 2. Documented reason for no assessment of left ventricular function (e.g. recent assessment of left ventricular function or patient refusal) 2. In-hospital Process-of-Care Indicators — Nonpharmacological

2.6 Smoking cessation advice, counselling or therapy during hospital stay NumeratorPatients with AMI who are smokers and who received smoking cessation advice, counselling or therapy during hospital stay DenominatorInclusions: 1. Confirmed AMI and 2. Active smoker or history of smoking in the past year Exclusions: Documented reason for no smoking cessation advice, counselling or therapy (e.g. patient refusal) 2. In-hospital Process-of-Care Indicators — Nonpharmacological

2.7 Referral to cardiac rehabilitation NumeratorPatients with AMI who are referred to cardiac rehabilitation during hospital stay or at discharge DenominatorInclusions: Confirmed AMI Exclusions: Documented reason for no referral to cardiac rehabilitation (e.g. patient-associated factors [e.g. patient refusal], provider-associated factors [e.g. patient with a high-risk condition or a contraindication to exercise], health care system-associated factors [e.g. financial obstacles or absence of a cardiac rehabilitation program near patient’s home]) 2. In-hospital Process-of-Care Indicators — Nonpharmacological

3.1 In-hospital mortality NumeratorPatients with AMI who died in hospital during this encounter/stay DenominatorInclusions: Confirmed AMI Exclusions: None 3. Outcome Indicator

4.1 Fibrinolytic therapy within 60 minutes after call for emergency medical services NumeratorPatients with AMI who were eligible for fibrinolytic therapy and received it within 60 minutes after call for emergency medical services DenominatorInclusions: 1. Confirmed AMI and 2. ST-segment elevation or new LBBB on ECG and 3. Fibrinolytic therapy within 6 hours after hospital arrival and 4. Fibrinolytic therapy is primary reperfusion therapy 5. Call made to emergency medical services (EMS) Exclusions: 1. In-field fibrinolysis 2. Walk-in patients 3. Documented reason for delay in receiving finbrinolytic therapy (e.g. patient refusal) 4. System Indicators

4.2 Primary percutaneous coronary intervention (PCI) within 120 minutes after call for emergency medical services NumeratorPatients with AMI who were eligible for PCI and received primary PCI within 120 minutes after call for emergency medical services DenominatorInclusions: 1. Confirmed AMI and 2. ST-segment elevation or new LBBB on ECG and 3. PCI performed within 24 hours after hospital arrival 4. Call made to emergency medical services (EMS) Exclusions: 1. Patients who received fibrinolytic therapy before PCI 2. Documentation of PCI as non-primary 3. Documented reason for delay in PCI (e.g. patient refusal) 4. System Indicators

4.3 Pre-hospital 12-lead ECG NumeratorPatients with AMI who had a prehospital 12-lead ECG done by emergency medical services personnel DenominatorInclusions: 1. Confirmed AMI and 2. Ambulance transportation Exclusions: 1. Walk-in patients 2. Documented reason for no prehospital ECG (e.g. patient refusal) 4. System Indicators

CCORT welcomes feedback on these indicators. Please send comments or questions to